Responses
Oncolytic and local immunotherapy
Original research
Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunity
Compose a Response to This Article
Other responses
No responses have been published for this article.